Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Chiba
Clinical trial register · Japan

Clinical Trials in Chiba, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2519 matching records held by the registry are in this view. Synced 19 Nov 2026, 03:18 UTC
2519
Studies in scope
all four open statuses
1286
Recruiting now
open to new participants
354
Lead sponsors
across recruiting studies
Top sites
Nagoya 45 Kashiwa-shi 41 Kyoto 25 Fukuoka 23 Sapporo 18

Trials with a site in Chiba

11 of 2519 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
AbbVie
Observational
200
Nagakute, Nagoya, Hirosaki, Chiba, Kashiwa-shi, Sakura, Fukuoka, Hiroshima
2025-10-09
Active, closed
AbbVie
Phase 3
421
Anjo, Nagoya, Chiba, Yoshida-gun, Fukuoka, Gifu, Maebashi, Fukuyama
2024-05-19
Active, closed
AbbVie
Observational
1,200
Nagoya, Toyoake, Hirosaki, Chiba, Sakura, Fukuoka, Fukushima, Asahikawa-shi
2024-02-19
Active, closed
AbbVie
Observational
1,019
Nagoya, Hirosaki-shi, Chiba, Sakura-shi, Chikushino-shi, Fukuoka, Asahikawa-shi, Sapporo
2023-06-09
Active, closed
AbbVie
Phase 3
520
Nagoya, Chiba, Kashiwa, Matsuyama, Kurume-shi, Sapporo, Akashi-shi, Yahaba
2023-03-15
Active, closed
AbbVie
Phase 3
330
Nagoya, Toyoake, Aomori, Chiba, Kashiwa-shi, Toon-shi, Fukuoka, Fukushima
2020-08-31
Active, closed
AbbVie
Phase 3
56
Chiba, Toon-shi, Maebashi, Sapporo, Tsukuba, Kita-gun, Kawasaki-shi, Yokohama
2020-02-04
Active, closed
AbbVie
Phase 2
270
Nagoya, Hirosaki-shi, Chiba, Matsuyama, Fukuoka, Kurume-shi, Fukuyama, Hiroshima
2018-10-10
Active, closed
AbbVie
Phase 3
1,242
Nagakute, Nagoya, Toyoake, Hirosaki-shi, Abiko-shi, Chiba, Kashiwa-shi, Sakura-shi
2018-08-28
Active, closed
AbbVie
Phase 3
1,336
Nagakute, Nagoya, Toyoake-shi, Abiko-shi, Chiba, Kashiwa-shi, Sakura-shi, Fukuoka
2018-04-09
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-japan/city/chiba

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,519 studies in total at the last sync on 19 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Chiba that also match the filters currently applied.

How many clinical trials are recruiting in Chiba?

1 of the 11 studies on this page are recruiting new participants as of the 19 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chiba), 11 studies
PhaseStudiesRecruitingShare
Phase 36054.5%
Observational3127.3%
Phase 22018.2%

Most active sponsors

Lead sponsors with the most studies (Chiba)
Lead sponsorStudiesRecruiting
AbbVie111
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.